Skip to content

You are reading 1 of 2 free-access articles allowed for 30 days

ICS would not rule out cannabis cancer research

However, the Society added that it does not recommend that patients who are receiving cancer treatment take cannabis in any form.

“All our recommendations and work is based on high-quality, peer-reviewed research. Several studies exist which are giving a better understanding of the complex ways in which cannabis affects the body and cancer. However, the results of most of these studies are preliminary,” the spokesperson said.

“As the results of most studies are preliminary, we don’t recommend it.”

The Society receives a wide variety of applications to fund cancer research.

“Each year, Irish Cancer Society Research runs a number of funding calls to encourage the development of cutting-edge cancer research and we actively encourage applications using all types of research methods and models. Applications to all programmes are assessed based on scientific excellence and quality of the applicant by an international peer-review panel and the final decision on applications to be funded lies with this panel alone. All our assessors are people of high international standing in the cancer research field.”

The spokesperson added that the “number of queries we receive per year on cannabis generally is small — just a handful, really”.

However, the Society has stressed that “cannabis smoking can do the same damage to the lungs as cigarette smoking” and greatly increases the risk of cancers such as lung cancer and mouth cancer.

Leave a Comment

You must be logged in to post a comment.

Scroll To Top